P19 embryonal carcinoma (EC) cells undergo apoptosis during neuronal differentiation induced by all-trans retinoic acid (RA). Caspase-3-like proteases are activated and involved in the apoptosis of P19 EC cells during neuronal differentiation. 1 Recently it has been shown that growth factor signals protect against apoptosis by phosphorylation of Bad. Phosphorylated Bad, an apoptotic member of the Bcl-2 family, cannot bind to Bcl-x L and results in Bcl-x L homodimer formation and subsequent antiapoptotic activity. In the present study, we demonstrate that this system is used generally to protect against apoptosis during neuronal differentiation. Bcl-x L inhibited the activation of caspase-3-like proteases. Basic fibroblast growth factor (bFGF) inhibited more than 90% of the caspase-3-like activity, inhibited processing of caspase-3 into its active form, and inhibited DNA fragmentation. bFGF activated phosphatidyl-inositol-3-kinase (PI3K) and stimulated the phosphorylation of Bad. Phosphorylation was inhibited by wortmannin, an inhibitor of PI3K and its downstream target Akt. Thus, Bad is a target of the FGF receptor-mediated signals involved in the protection against activation of caspase-3.
Introduction
Considerable evidence suggests that caspases are involved in apoptosis of various cells. 2 Caspases are activated from their inactive proforms in a sequential cascade of cleavage. 3 Of members of the caspase family, caspase-3, which is the farthest downstream in this cascade, is activated by processing of procaspase-3 (p32) into its active form (p20/ 17 and p12) during apoptosis. 4 Caspase-3 has been shown to play an essential role in programmed cell death in the nervous system during development. 5 ± 8 P19 EC cells differentiate into neuronal cells after treatment with all-trans retinoic acid (RA) in the aggregate form and are a good model system to study the molecular mechanism of neuronal differentiation from pluripotent cells. 9 During RA-induced neuronal differentiation of P19 EC cells, many cells die or exhibit hallmarks of apoptotic cell death including cytoplasmic contraction and DNA fragmentation. 10, 11 RA-induced apoptosis of P19 EC cells can be inhibited by Bcl-2. 11 We isolated mouse caspase-3 and -7 from P19 EC cells cDNA library 6 and subsequently showed that caspase-3-like activity is increased during RAinduced neuronal differentiation and apoptosis of P19 EC cells, and that caspase-3-like proteases are involved in apoptosis of P19 EC cells. 1 Recently the relation between survival signals and the mechanism underlying the cell death has been studied. IL-3 activates Raf-1 and stimulates the phosphorylation of Bad, a member of the Bcl-2 family, resulting in an inhibition of heterodimeric complex formation with Bcl-x L . 12 Insulin-like growth factor inhibits the activation of caspase-1 induced by serum deprivation. 13 In the vertebrate nervous system, neurotrophic factors are essential for survival of specific sensory organ neurons.
14 Lack of neurotrophic factor signals induces apoptosis in the sensory neurons, including dorsal root ganglion (DRG) neurons. We recently demonstrated a relation between the activation of caspase-3-like proteases and apoptosis induced by lack of neurotrophic factors; 6 caspase-3-like activity increases when apoptosis of DRGs is induced by nerve growth factor (NGF) deprivation.
Phosphatidyl-inositol-3-kinase (PI3K), a downstream effector of various growth factor signals, 15, 16 is also involved in cell survival. Wortmannin, an inhibitor of PI3K, 17 prevents the ability of NGF to inhibit apoptosis induced by serum withdrawal. 18 Wortmannin enhances caspase-3-like activity and apoptosis in RA-treated P19 EC cells as well as TNF-treated U937 cells and anti-Fastreated Jurkat cells. 1, 19 Thus survival factors negatively regulate the activation of caspase-3-like proteases.
Here we demonstrate that basic fibroblast growth factor (bFGF) specifically inhibits activation of caspase-3-like proteases, including caspase-3, during neuronal differentiation of P19 EC cells by activating a downstream target of PI3K.
Results bFGF inhibits caspase-3-like protease activation and DNA fragmentation Caspase-3-like activity and DNA fragmentation were increased during neuronal differentiation of P19 EC cells induced by RA (1 mM) (Figure 1 ). Caspase-3-like activity was increased at 24 h after RA application, plateaued at 30 h and then decreased ( Figure 1A ). The active form of caspase-3 (p17) was detected at 30 h after RA treatment ( Figure 1B ). The DNA fragmentation appeared concomitant with the increase in caspase-3-like protease activities ( Figure 1C ). The caspase-3-like activity, appearance of p17, and DNA fragmentation induced by RA were inhibited by bFGF (10 ng/ ml) (Figure 1 ), but the neuronal differentiation induced by RA was not inhibited (unpublished observation). These results suggest that bFGF signaling blocks apoptosis of differentiating neurons by inhibiting the activation of caspase-3-like proteases. Similarly, inhibition of caspase-3-like activity by Ac-DEVD-CHO, a specific inhibitor, blocks DNA fragmentation. 1 Caspase-3-like activity was inhibited in a dose-dependent manner by bFGF (1 ± 10 ng/ml). More than 90% of the activity was inhibited by bFGF at 1 ng/ml, and 70% of the activity was inhibited by epidermal growth factor (EGF) at 10 ng/ml. Hepatocyte growth factor (HGF, 10 ng/ml) and NGF (10 ng/ml) inhibited 30 and 35% of the caspase-3-like activity induced by RA, respectively (Figure 2A ). Of the FGF family members tested, bFGF and FGF9 preferentially inhibited caspase-3-like activity in P19 EC cells treated with RA, while acidic FGF (aFGF) and FGF4 had moderate inhibitory effects, and FGF7 had a very weak inhibitory effect ( Figure 2B ).
Involvement of FGF receptor signals in the inhibition of caspase-3-like proteases
To date, four FGF receptor (FGFR) genes have been isolated. 20 Expression of mRNA for the four FGFRs was examined by reverse transcription-polymerase chain reaction (RT ± PCR) in P19 EC cells during neuronal differentiation ( Figure 3A ). FGFR1 and 2 showed two (597 and 330 bp) and three (629, 383, and 289 bp) different size of RT ± PCR fragments, respectively. DNA sequence analysis confirmed that these are alternative splice products of FGFR1 and 2. The expression of FGFR1 (597 and 330 bp), FGFR2 (383 and 289 bp), and FGFR3 (446 bp) was detected consistently at high levels during neuronal differentiation, and the expression of FGFR4 (550 bp) gradually decreased.
Because FGFRs possess receptor tyrosine kinase activity, we examined whether tyrosine kinase signals are involved in the bFGF-mediated inhibition of caspase-3-like protease activation and apoptotis induced by RA. As shown Figure 3B , herbimycin A, a tyrosine kinase inhibitor, enhanced RA induction of caspase-3-like activity and prevented the ability of bFGF to inhibit it. These results suggest that activation of caspase-3-like proteases is negatively regulated downstream of growth factor receptor tyrosine kinase activation including FGFR kinase activation. Effects of pulse treatment of bFGF on the activation of caspase-3
To specify when bFGF efficiently inhibits the activation of caspase-3 during neuronal differentiation, we examined the effect of pulse treatment of bFGF. Caspase-3-like activity was inhibited by pulse treatment (3 h) with bFGF after RA treatment. Pulse treatment with bFGF at 0 h after RA addition inhibited 60% of caspase-3-like activity. At 10 and 20 h after RA treatment, bFGF pulse treatment inhibited more than 80% of this activity. Interestingly, even at 30 h, when caspase-3-like proteases had already been activated, bFGF successfully inhibited 60% of the activity within 3 h ( Figure 4A ). bFGF inhibited the processing of caspase-3 within 1 h, correlating with the decrease in caspase-3-like activity ( Figure 4B and C) . The active fragment of caspase-3 (p17) rapidly disappeared after bFGF treatment. Thus, pulse treatment with bFGF as well as continuous treatment inhibited the processing of caspase-3. This indicates that inhibition of caspase-3 by bFGF is not due to the prevention of the neuronal differentiation, but due to the direct influence of the FGFR-mediated phosphorylation signals.
Inhibition of caspase-3-like proteases by Bcl-x L
The effect of Bcl-x L on caspase-3 was examined ( Figure 5 ). Cells overexpressing Bcl-x L differentiated normally into Map-2-positive neurons under the condition used (unpublished observation). Caspase-3-like protease activity during neuronal differentiation induced by RA was much lower in cells 
Phosphorylation of Bad in response to bFGF treatment
Bcl-x L forms a heterocomplex with unphosphorylated Bad, an apoptotic member of the Bcl-2 family, but not with phosphorylated Bad. 12 Recently, it has been shown that Bad is phosphorylated by Akt, a downstream target of PI3K. 21 As shown in Figure 6A , bFGF time-dependently activated PI3K, and this activity was sensitive to treatment with wortmannin. bFGF stimulated phosphorylation of Bad, and this phosphorylation was also inhibited by wortmannin ( Figure  6B ). In correlation with the phosphorylation of Bad, the processing of caspase-3 was decreased. Wortmannin partially prevented the ability of bFGF to inhibit the processing of caspase-3.
Discussion
Molecular mechanism by which bFGF inhibits caspase-3 activation and DNA fragmentation
The FGF signaling pathway involves a large number of FGFs and at least four receptors. 20 FGF family members can share receptors and affect a variety of biological functions including proliferation, morphogenesis, and suppression of apoptosis during development via a more complex signal transduction system. FGFs protect against apoptosis of various cells including endothelial cells, 22 lens cells, 23 and oligodendroglia cells 24 during development, and protect neurons against hypoxia-or oxygen-induced apoptosis. 25, 26 Recently, we found that FGFs are involved in the protection against apoptosis of neuroepithelial cells (unpublished observation). In the present study, we demonstrated that bFGF protected against the apoptosis during neuronal differentiation of P19 EC cells by inhibiting the activation of caspase-3-like proteases.
Since bFGF has an ability to inhibit the differentiation of neural stem cells, 27 the possibility arises that bFGF inhibits caspase-3 activation by preventing the neuronal differentiation of P19 EC cells. However, this possibility is unlikely in our case, because pulse treatment of bFGF as well as continuous treatment inhibited the caspase-3 activation in the RA-treated P19 EC cells within 1 ± 3 h (Figure 4) . Furthermore, bFGF-treated P19 EC cells or Bcl-x L -overexpressing P19 EC cells as well as untreated cells differentiate normally into Map-2-positive neurons; percentage of Map-2-positive cells did not change in response to bFGF treatment or Bcl-x L expression (unpublished observation). These results indicate that the inhibition of caspase-3 induced by bFGF and Bcl-x L is not related to the inhibition of the neuronal differentiation.
FGFR signals inhibiting the activation of caspase-3
Herbimycin A blocked the bFGF-mediated inhibition of caspase-3-like activity ( Figure 3B ), suggesting that activation of caspase-3 is regulated by FGFR-mediated phosphorylation signals. Pulse treatment of bFGF rapidly decreased the level of the active form fragment (p17) as well as caspase-3-like activity (Figure 4 ), suggesting that FGFR-mediated phosphorylation signals inhibit the activation of upstream caspase-3 processing enzyme. Active form (p17) may be very sensitive Arrowheads and arrows indicate phosphatidyl-inositol-3-phosphate and the position which samples are applied, respectively. Left panel; After P19 EC cells were cultured with RA in the aggregate form for 24 h, bFGF (10 ng/ml) was added. PI3K activity was measured at the indicated times after addition of bFGF. Right panel; After P19 EC cells were cultured with RA (1 mM) in the aggregate form for 24 h, bFGF (10 ng/ml) and wortmannin at the indicated concentrations were added. PI3K activity was measured at 20 min after addition of bFGF and wortmannin. WT indicates wortmannin. (B) The effect of bFGF and wortmannin on the phosphorylation of Bad and processing of caspase-3 induced by RA. After FLAG-tagged Bad was transfected into P19 EC cells and incubated with RA for 24 h, bFGF (10 ng/ml) and wortmannin (100 nM) were added. Phosphorylation and processing of caspase-3 was examined at 30 min after addition of bFGF or and wortmannin to degradation enzymes, and degrade rapidly after inhibition of the processing enzyme.
The relation between growth factor signals and apoptosis has been a topic of recent interest. Bad promotes cell death by heterodimerizing with Bcl-2 or Bcl-x L cell death antagonists. 12, 28 Survival factors IL-3 and Raf-1 inhibit the function of Bad through phosphorylation; phosphorylated Bad fails to bind to Bcl-x L , promoting the formation of the Bcl-x L homodimer complex, which serves an antiapoptotic function. Bcl-x L inhibits the activation of caspase-9, one of the processing enzyme of caspase-3.
29 PI3K is a signaling molecule associated with growth factor receptors that are involved in cell proliferation. 30 Akt, one of the downstream targets of PI3K, is known to regulate neuronal survival. 31 Like Bad phosphorylated by IL-3 or Raf-1, Bad phosphorylated by Akt promotes the formation of Bcl-x L homodimer complexes and antiapoptotic activity, 12, 32 suggesting that the activated PI3K-Akt pathway is one way in which growth factors protect against apoptosis.
bFGF activated PI3K and stimulated phosphorylation of Bad, while wortmannin, an inhibitor of PI3K 17 and its downstream target Akt, 33 inhibited the phosphorylation of Bad induced by bFGF ( Figure 6 ). The level of Bad phosphorylation correlated with the level of the caspase-3 active fragment induced by bFGF, suggesting that Bad is one of the targets of the PI3K-Akt pathway. Thus, activation of the PI3K-Akt pathway by FGFR may promote the antiapoptotic function of Bcl-x L through phosphorylation of Bad. However, the possibility should not be excluded that phosphorylation of other Bcl-2 family members or their downstream targets including caspase-9 and downstream of caspase-3, for example, the X-linked apoptosis-inhibition protein (XAIP), 34 may be involved in FGFR-mediated protection against caspase-3 activity.
Materials and Methods
Cell culture P19 EC cells, originally established by McBurney et al. 9 were kindly donated by Dr. Hamada (Osaka University, Osaka, Japan). Neuronal differentiation of P19 EC cells was induced by following conditions originally described by McBurney et al.
9 P19 EC cells were cultured in the aggregate form in the presence of 1 mM RA in bacterial dishes for 2 days and then cultured in the non-aggregate form in the absence of RA for 2 days in cell culture dishes. All experiments were performed in the aggregate culture condition with RA (1 mM) unless otherwise noted.
Isolation of fragmented DNA
DNA isolation was performed according to Prigent et al. 35 with some modification. P19 EC cells treated with RA alone or RA plus bFGF (Mallinckrodt Inc, Paris, KY, USA) were lysed with 400 ml of lysis buffer (20 mM Tris-HCl pH 7.4, 20 mM EDTA and 1% Triton X-100). Lysis was allowed to proceed on ice for 10 min and the mixture was centrifuged for 10 min at 10 0006g. The supernatant was digested with 50 mg/ml RNase A at 378C for 1 h. This was followed by a proteinase K digestion at 50 mg/ml at 378C for 1 h. After phenolchloroform extraction, the DNA was then precipitated by adding 2.5 vol of 100% ethanol and CH 3 COONa (0.3 M final concentration). DNA ladders were visualized on 1.8% Nusieve agarose (Takara, Kyoto, Japan) gel.
Caspase-3-like activity P19 EC cells were cultured with RA in the aggregated form for 48 h. To examine the effect of growth factors and kinases on caspase-3-like activity, P19 EC cells were incubated with RA in the presence or absence of various growth factors including aFGF (UBI, Lake Plasid, NY, USA), bFGF, FGF4 (R&D Systems Inc, Minneapolis, MN, USA), FGF7 and FGF9 (Pepro Tech Inc, London, England), EGF and HGF (TOYOBO, Osaka, Japan), and NGF (Wako, Osaka, Japan) or herbimycin A (Wako) at the indicated concentrations for various periods. After incubation, cells were washed twice with phosphatebuffered saline (PBS), and the cell pellets were lysed in PBS containing 0.2% Triton X-100 on ice for 10 min. After centrifugation at 10 0006g for 5 min, the cell extracts (50 mg protein) were incubated with 10 mM Ac-DEVD-MCA (Peptide Institute, Osaka, Japan), a synthetic peptide of the cleavage site of poly-ADP ribose polymerase, in incubation buffer (50 mM Tris-HCl pH 7.5, 1 mM DDT) at 378C for 20 min in order to measure caspase-3-like activity. The reactions were halted by the addition of 10% sodium dodecyl sulfate (SDS). Fluorescence intensity was measured at 380 nm for excitation and at 460 nm for emission.
Assay of PI3K activity
Activity of PI3K was assayed as described by Arcaro and Wymann. 17 P19 EC cells were incubated with bFGF and wortmannin at various concentrations (1 ± 1000 nM) and lysed in lysis buffer (200 mM TrisHCl pH 7.5, 1 mM MgCl 2 , 1 mM CaCl 2 , 137 mM NaCl, 1 mM NaVO4, 1% NP-40, 10% glycerol, 1 mM PMSF, 10 mg/ml leupeptin). After centrifugation at 13 0006g for 10 min, the supernatant was incubated with anti-PI3K (p85) (MBL, Nagoya, Japan) at 48C overnight. The immunocomplex was precipitated with a mixture of protein A and G (Promega, Madison, WI, USA), and suspended in 20 ml of 20 mM HEPES buffer (pH 7.4). The immunocomplex was incubated with 1 mCi [ 32 P]g-ATP in the reaction buffer containing phosphatidylinositol (200 mg/ml) and phosphatidylserine (200 mg/ml) at 258C for indicated period and then subjected to thin layer chromatography. The thin layer plate (Merck, Darmstadt, Germany) was developed with chloroform/ methanol/25% ammonia/H 2 O (86 : 76 : 8.9 : 15.1). After development, the thin layer was exposed to a Fuji image analyzer.
RT ± PCR assay
The expression of FGFRs in P19 EC cells during neuronal differentiation was examined by RT ± PCR using the following primers; 20 5'-TTCTGGGCTGTGCTGGTCAC-3' and 5'-GCGAACCT-TGTAGCCTCCAA-3' for FGFR1, 5'-TTCATCTGCCTGGTCTTGGT-3' and 5'-AATAAGGCTCCAGTGCTGGTTTC-3' for FGFR2, 5'-CTAGTG-TTCTGCGTGGCGGT-3' and 5'-TTCTTATCCATTCGCTCCGG-3' for FGFR3, 5'-CTGTTGAGCATCTTTCAGGG-3' and 5'-CGTGGAAGGC-CTGTCCATCC-3' for FGFR4. Total RNA was prepared from P19 EC cells using the guanidium thiocyanate method. 36 Total RNA (1 mg) was subjected to RT ± PCR as described in the manual from Perkin-Elmer, 1 cycle at 958C for 2 min, 30 cycles at 958C for 1 min and at 608C for 2 min, and 1 cycle at 608C for 7 min. The PCR products were subjected to 3% Nusieve gel (Takara) electrophoresis. The identity of the PCR products was confirmed by DNA sequence analysis.
Immunoblot analysis of caspase-3 cleavage
To detect the cleavage of mouse caspase-3, we prepared a cleavage site-directed antiserum against human and mouse caspase-3 (anti-p20/17). 7, 8, 19 Cell pellets were lysed in PBS containing 0.2% Triton X-100 on ice for 10 min. After centrifugation at 10 0006g for 10 min, the cell extracts (30 mg protein) were subjected to SDS gel (12%) electrophoresis. Proteins were electrophoretically transferred to nitrocellulose filters. After the filters were incubated with anti-p20/17, immunoreactivity was detected by alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin (Promega) and nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-1-phosphate.
P19 EC cells overexpressing Bcl-x L
Rat bcl-x L was inserted into the EcoRI site of the pMKIT-Neo expression vector. PMKIT-Neo-bcl-x L was transfected into P19 EC cells according to the calcium-phosphate method 37 and cells expressing Bcl-x L were selected by incubating them in the presence of G418 (500 mg/ml) for 2 weeks. The expression of Bcl-x L was detected by immunoblot analysis using anti-Bcl-x L . Cells overexpressing Bcl-x L were differentiated into neuronal cells by incubation in the presence of RA.
Phosphorylation of Bad by bFGF
Full-length mouse Bad was obtained by RT ± PCR of total RNA from mouse embryos using the following primers; 5'-ACGAATT-CAATGGGAACCCCAAAGCAGCCC-3' and 5'-ATGAATTCT-CACTGGGAGGGGGTGGAGC-3'. 38 Isolated mouse Bad was inserted into the EcoRI site of the FLAG-tagged CMV expression vector (Kodak, New Haven, CT, USA) and transfected into P19 EC cells. At 12 h after transfection, the transfected P19 EC cells were incubated with RA in the aggregate form for 24 h, and then incubated further with RA in the presence or absence of bFGF and or wortmannin (Sigma, St Louis, MO, USA) in phosphate-free medium with 32 P (50 mCi/ml) for 30 min and then lysed in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM Na 3 VO 4 , 10 mM NaF, 1 mg/ml leupeptin). After centrifugation at 10 0006g for 10 min, the cell extracts (100 mg protein) were incubated with anti-Bad antibody (MBL) and precipitated with Sepharose-conjugated protein A and G. The immunoprecipitation complex was subjected to SDS gel (12%) electrophoresis. After transfer to nitrocellulose filters, immunoreactivity was detected by anti-FLAG (Kodak) and alkaline phosphatase-conjugated goat antimouse immunoglobulin (Promega). The immunoreactivity was detected by nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-1-phosphate. The filter was also exposed to a Fuji image analyzer.
